Anavex Life Sciences (AVXL) Shares Outstanding (Diluted) (2010 - 2026)
Anavex Life Sciences' Shares Outstanding (Diluted) was 92.9 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 8.8% from 85.38 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Shares Outstanding (Diluted) at Anavex Life Sciences came in at 85.29 million, up 2.2% from FY2024.
- Shares Outstanding (Diluted) has now increased for five consecutive fiscal years, with a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- In earlier fiscal years, Shares Outstanding (Diluted) was 83.47 million in FY2024 (+4.6%), 79.79 million in FY2023 (+3.7%), 76.91 million in FY2022 (+10.2%) and 69.8 million in FY2021 (+69.6%).
- The fiscal Q3 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q4 2010.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 20 straight quarters, with growth averaging 4.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 1.0% (fiscal Q3 2025) to 69.6% (fiscal Q3 2022).
- Per Business Quant data, AVXL's Shares Outstanding (Diluted) in the three fiscal quarters before Q3 2026 was 92.68 million (Q2 2026), 89.03 million (Q1 2026) and 85.29 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - | 92.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.90 Mn |
| Mar 31, 2026 | 92.68 Mn |
| Dec 31, 2025 | 89.03 Mn |
| Sep 30, 2025 | 85.29 Mn |
| Jun 30, 2025 | 85.38 Mn |
| Mar 31, 2025 | 85.07 Mn |
| Dec 31, 2024 | 84.81 Mn |
| Sep 30, 2024 | 83.47 Mn |
| Jun 30, 2024 | 84.54 Mn |
| Mar 31, 2024 | 82.46 Mn |
| Dec 31, 2023 | 82.08 Mn |
| Sep 30, 2023 | 79.79 Mn |
| Jun 30, 2023 | 80.88 Mn |
| Mar 31, 2023 | 78.30 Mn |
| Dec 31, 2022 | 77.98 Mn |
| Sep 30, 2022 | 76.91 Mn |
| Jun 30, 2022 | 69.80 Mn |
| Mar 31, 2022 | 69.80 Mn |
| Dec 31, 2021 | 69.80 Mn |
| Sep 30, 2021 | 69.80 Mn |
API Access
Anavex Life Sciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();